Invention Grant
- Patent Title: Method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist
-
Application No.: US15312515Application Date: 2015-05-15
-
Publication No.: US10023649B2Publication Date: 2018-07-17
- Inventor: Chia-Yang Lin , Shihao Chen , LiFen Lee , Shobha Potluri , Denis Healy , Margaret Marshall , Naoki Sawada
- Applicant: Pfizer Inc. , KYOWA HAKKO KIRIN CO., LTD.
- Applicant Address: US NY New York JP Chiyoda-ku, Tokyo
- Assignee: Pfizer Inc.,Kyowa Hakko Kirin Co., Ltd.
- Current Assignee: Pfizer Inc.,Kyowa Hakko Kirin Co., Ltd.
- Current Assignee Address: US NY New York JP Chiyoda-ku, Tokyo
- Agency: Arnold & Porter Kaye Scholer LLP
- International Application: PCT/US2015/031081 WO 20150515
- International Announcement: WO2015/179236 WO 20151126
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61K39/395 ; A61K47/18 ; A61K47/26 ; A61K47/12 ; A61K39/00
Abstract:
The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer.
Public/Granted literature
- US20170088627A1 COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER Public/Granted day:2017-03-30
Information query
